Fresenius Medical Care AG & Co. KGaA Published Form 20-F for the Fiscal Year 2016
April 10 2017 - 4:53AM
Business Wire
Fresenius Medical Care AG & Co. KGaA ("the company" or
"Fresenius Medical Care"), the world's largest provider of dialysis
products and services, announced that it has filed the annual
report 2016 under form 20-F with the U.S. Securities and Exchange
Commission (SEC). The report is available at the company's website
www.freseniusmedicalcare.com in the "Investors" section as well as
at the SEC's website, www.sec.gov.
A hard copy of Fresenius Medical Care's annual report on form
20-F including the complete audited financial statements may be
obtained from the company free of charge upon request to the
company's Investor Relations department by email at
ir@fmc-ag.com.
Fresenius Medical Care is the world's largest provider of
products and services for individuals with renal diseases of which
around 3 million patients worldwide regularly undergo dialysis
treatment. Through its network of 3,624 dialysis clinics, Fresenius
Medical Care provides dialysis treatments for 308,471 patients
around the globe. Fresenius Medical Care is also the leading
provider of dialysis products such as dialysis machines or
dialyzers. Along with the core business, the company focuses on
expanding the range of related medical services in the field of
Care Coordination. Fresenius Medical Care is listed on the
Frankfurt Stock Exchange (FME) and on the New York Stock Exchange
(FMS).
For more information visit the Company's website at
www.freseniusmedicalcare.com.
Disclaimer
This release contains forward-looking statements that are
subject to various risks and uncertainties. Actual results could
differ materially from those described in these forward-looking
statements due to certain factors, including changes in business,
economic and competitive conditions, regulatory reforms, foreign
exchange rate fluctuations, uncertainties in litigation or
investigative proceedings, and the availability of financing. These
and other risks and uncertainties are detailed in Fresenius Medical
Care AG & Co. KGaA's reports filed with the U.S. Securities and
Exchange Commission. Fresenius Medical Care AG & Co. KGaA does
not undertake any responsibility to update the forward-looking
statements in this release.
Language: English Company: Fresenius Medical Care AG &
Co. KGaA Else-Kr�ner-Straße 1 61352 Bad Homburg Germany Phone: +49
(0) 6172- 609 2525 Fax: +49 (0) 6172- 609 2301 E-mail:
ir@fmc-ag.com
Internet:
www.freseniusmedicalcare.com
ISIN:
DE0005785802
WKN: 578580, 578583 Indices: DAX Listed: Regulated Market in
Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin,
Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate
Exchange; NYSE
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170410005499/en/
Fresenius Medical CareName:Dominik HegerTel:+49 (0)6172 - 609
2525Email:dominik.heger@fmc-ag.com,tanja.huettl@fmc-ag.com
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Apr 2023 to Apr 2024